JERSEY CITY, N.J.--(BUSINESS WIRE)--Lux Biosciences, Inc., a privately held biotechnology company specialized in the field of ophthalmic diseases, announced today the appointment of Brett A. Skolnik as Chief Financial Officer. Mr. Skolnik was previously a managing director in the Health Care Group at Piper Jaffray & Company.
